Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2020-06-25 Regulatory Filings
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Patents granted in the United States
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0006R' and is dated June 25, 2020. It announces a specific corporate event: the granting of two patents in the United States for Eden Research plc's technology. The text is a news announcement format, typical of regulatory dissemination services. Since it is a specific, material announcement that doesn't fit the definitions for ER, IR, 10-K, or a specific corporate action like DIV or CAP, and it is clearly disseminated via the London Stock Exchange's news service (RNS), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements not covered by more specific codes.
2020-06-25 English
Result of AGM
AGM Information Classification · 99% confidence The document is identified by the RNS Number (9600Q) and explicitly states it is an announcement regarding the 'Result of AGM' (Annual General Meeting). It confirms that 'all the resolutions were duly passed' at the AGM held on June 24, 2020. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or in this case, the outcome thereof. Although it is an RNS announcement, the specific content relates directly to the AGM results, making AGM-R the most precise classification over the general RNS fallback.
2020-06-24 English
Issuing of Annual Report & Notice of AGM
AGM Information Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 3482O' and the closing boilerplate referencing RNS and the London Stock Exchange). The subject line explicitly states 'Issuing of Annual Report & Notice of AGM'. This means the document is announcing the availability of two key items: the Annual Report and the Notice of the Annual General Meeting (AGM). Since the document itself is an announcement about the publication of reports rather than the full content of the Annual Report (10-K) or the detailed proxy materials (DEF 14A/PSI), it fits best under the category for announcing report publications (RPA) or the general regulatory filing category (RNS). Given that it specifically announces the issuance of the Annual Report and the AGM Notice, and it is a short regulatory news service release, classifying it as a Report Publication Announcement (RPA) is highly appropriate, as it follows the 'MENU VS MEAL' rule by announcing the availability of the full reports. However, since the content heavily features the AGM notice and the release of the Annual Report, and RNS is the source, RPA is the most precise fit for an announcement of publication.
2020-05-29 English
Update on Bayer Animal Health Agreement
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 9990N' and is dated May 27, 2020. It announces an 'Update on Bayer Animal Health Agreement' and contains contact information typical of a regulatory news service release. The presence of the RNS Number and the closing statement referencing RNS as the news service of the London Stock Exchange strongly indicates this is a general regulatory announcement. Since the content is a specific business update (amendment to a license agreement) and not a formal financial report (like 10-K or IR), nor a specific event like a dividend or AGM, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard market disclosure.
2020-05-27 English
New authorisations for Cedroz and Mevalone
Environmental & Social Information Classification · 99% confidence The document begins with 'RNS Number : 4080N' and is dated May 20, 2020. It announces regulatory updates regarding product authorizations (Cedroz™ and Mevalone™) received by its commercial partner, Eastman, in Italy and the Netherlands, and an expanded use in Greece. The content is a news announcement detailing operational and regulatory progress, not a comprehensive financial report (like 10-K or IR) or a transcript. The presence of the RNS identifier strongly suggests it is a regulatory news service announcement. Since it details specific operational news (product authorizations) rather than being a general regulatory filing fallback, and it is not a formal financial report, it fits best under the general Regulatory Filings category (RNS) as it is distributed via the RNS system, although it contains elements of an operational update. Given the context of RNS distribution and the nature of the announcement (regulatory progress updates), RNS is the most appropriate classification.
2020-05-20 English
Financial Results for Year Ended 31 December 2019
Earnings Release Classification · 100% confidence The document is an 'Earnings Release' (ER) for Eden Research plc for the year ended 31 December 2019. It contains key financial highlights (revenue, operating loss, loss per share), commercial and operational highlights, a post-period update, and a Chairman's statement. It is not a full Annual Report (10-K) as it is a summary announcement of preliminary results, and it is not an RPA because it contains substantive financial data and analysis rather than just an announcement of a report's availability. FY 2019
2020-05-07 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.